+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunoglobulin for intravenous use



Immunoglobulin for intravenous use



Transfusion Medicine 7(1): 67-69




(PDF emailed within 0-6 h: $19.90)

Accession: 046333241

Download citation: RISBibTeXText

PMID: 9089990

DOI: 10.1046/j.1365-3148.1997.d01-83.x


Related references

Stabilizers and osmolarity of intravenous immunoglobulin drugs A necessity to evaluate a final therapeutic preparation in prescribing an intravenous immunoglobulin. Immunologiya 25(3): 177-182, 2004

Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. Journal of Pediatrics 163(2): 521-526, 2013

Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia. Journal of Pediatric Hematology/Oncology 33(4): 265-269, 2011

Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clinic Proceedings 75(1): 83-85, 2000

In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfusion Medicine 12(2): 133-139, 2002

Retrospective analysis of weekly intravenous immunoglobulin prophylaxis versus intravenous immunoglobulin by IgG level monitoring in hematopoietic stem cell transplant recipients. American Journal of Hematology 87(2): 172-174, 2013

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. Bmc Pediatrics 18(1): 200, 2018

Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. JAMA 268(4): 483-488, 1992

Use of immunoglobulin (Ig) in peripheral neuropathies. Impact of Ig on remission rates: comparison of intravenous immunoglobulin and subcutaneous immunoglobulin. Clinical and Experimental Immunology 178 Suppl 1: 25-26, 2015

Long-term follow up of patients with common variable immunodeficiency treated with intravenous immunoglobulin: reevaluation of intravenous immunoglobulin replacement therapy. IVIG therapy in CVID. BioTherapy 7(2): 101-107, 1993

Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation. Scandinavian Journal of Immunology 51(4): 408-414, 2000

Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model. Infection 15 Suppl 2: S51-S59, 1987

Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model. Infection 15(1): 60-68, 1987

Use of an immunoglobulin a depleted intravenous immunoglobulin in a patient with an anti immunoglobulin a antibody. Clinical Immunology & Immunopathology 38(2): 141-149, 1986

Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Pediatric Infectious Disease Journal 13(6): 477-484, 1994